Istituto di Candiolo Fondazione del Piemonte per l Oncologia IRCCS

Candiolo to 10060

0 studies enrolling now · 2 studies all time

What they study most

Small Cell Lung Cancer, Solid Tumors

Studies at this site

• A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Stopped early
• Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC) — Running, not enrolling